Name | Price | 30 day Chg | EPS | P/E | PEG | Div Yield | Market Cap (m) | Broker Rec | Annual Report | |
Acceler8 Ventures | 170.00p | -10.53% | -0.070p | n/a | 0.0 | 0.00% | £1.28 | n/a | - | n/a |
Acg Acquisition Company Limited Cls A Npv (DI) | $15.50 | -6.06% | -672.82¢ | n/a | 0.0 | 0.00% | $0.06 | n/a | - | n/a |
Admiral Acquisition Limited Npv (Di) | $9.32 | 1.08% | 25.45¢ | 36.6 | 0.0 | 0.00% | $503.32 | n/a | - | n/a |
Ajax Resources | 3.00p | -20.00% | -1.84p | n/a | 0.0 | 0.00% | £1.41 | n/a | - | n/a |
Anemoi International Ltd NPV (DI) | 0.68p | 0.00% | -1.00p | n/a | 0.0 | 0.00% | £1.30 | n/a | - | n/a |
Aquila European Renewables | 0.72 | -8.57% | 3.03p | 23.8 | 71.8 | 7.65% | 293.92 | n/a | - | n/a |
Aquila European Renewables (GBP) | 61.90p | -8.63% | 3.03p | 23.8 | 71.8 | 7.65% | £234.06 | n/a | - | n/a |
Ashington Innovation | 1.38p | -15.38% | -0.99¢ | n/a | 0.0 | 0.00% | £0.84 | n/a | - | n/a |
Aura Renewable Acquisitions | 5.75p | 0.00% | -3.50p | n/a | 0.0 | 0.00% | £0.60 | n/a | - | n/a |
Bay Capital | 7.00p | -45.10% | -1.85p | n/a | 0.0 | 0.00% | £4.90 | n/a | - | n/a |
Beacon Rise Holdings | 80.00p | 6.67% | -10.62p | n/a | 0.0 | 0.00% | £0.94 | n/a | - | n/a |
Becket Invest | 1.10p | 0.00% | -8.50p | n/a | 0.0 | 0.00% | £0.90 | n/a | - | n/a |
Celadon Pharmaceuticals | 102.50p | 0.00% | n/a | n/a | n/a | n/a | £65.81 | n/a | - | n/a |
Chesterfield Resources | 0.45p | 0.00% | -1.44p | n/a | 0.0 | 0.00% | £0.59 | n/a | - | n/a |
daVictus | 4.25p | 0.00% | 0.68p | 6.2 | n/a | 0.00% | £0.52 | n/a | - | n/a |
DG Innovate | 0.11p | -39.44% | -4.00p | n/a | 0.0 | 0.00% | £11.03 | n/a | - | n/a |
Emmerson NPV | 2.20p | -12.00% | 0.34¢ | 8.1 | 2.7 | 0.00% | £25.06 | n/a | - | n/a |
Future Metals Nl (DI) | 1.32p | -5.36% | -1.82¢ | n/a | 0.0 | 0.00% | £7.41 | Overweight | - | n/a |
GS Chain | 0.97p | -11.36% | -0.17p | n/a | 0.0 | 0.00% | £3.90 | n/a | - | n/a |
Invesco Markets Invesco FTSE 250 Ucits ETF | 17,084.00p | 6.12% | n/a | n/a | n/a | n/a | £59.76 | n/a | - | n/a |
Kelso Group Holdings | 2.75p | -5.17% | 0.56p | 4.9 | 0.0 | 0.00% | £10.33 | n/a | - | n/a |
Mac Alpha Limited NPV (DI) | 175.00p | 0.00% | -36.25p | n/a | 0.0 | 0.00% | £1.23 | n/a | - | n/a |
Marwyn Acquisition Company III Limited (DI) | 0.000p | 0.00% | -11.43p | 0.0 | 0.0 | 0.00% | n/a | n/a | - | n/a |
More Acquisitions | 0.68p | 12.50% | -0.37p | n/a | 0.0 | 0.00% | £1.08 | n/a | - | n/a |
Oneiro Energy | 10.00p | 0.00% | -2.72p | n/a | 0.0 | 0.00% | £4.45 | n/a | - | n/a |
Portugal Fund Ltd. IDR'S | $0.00 | 0.00% | n/a | n/a | n/a | n/a | n/a | n/a | - | n/a |
Red Capital | 29.50p | -6.35% | -2.13p | n/a | 0.0 | 0.00% | £2.95 | n/a | - | n/a |
Rights & Issues Investment Trust | 2,270.00p | 7.58% | 50.40p | 45.0 | 1.5 | 1.89% | £121.21 | n/a | - | n/a |
Roquefort Therapeutics | 4.55p | -41.29% | -1.35p | n/a | 0.0 | 0.00% | £5.88 | n/a | - | n/a |
Supply@Me Capital | 0.025p | -28.57% | 0.007p | n/a | 0.0 | 0.00% | £15.31 | n/a | - | n/a |
450 | 2.10p | 16.67% | -0.12p | n/a | 0.0 | 0.00% | £0.44 | n/a | - | n/a |
Geiger Counter Limited | 55.10p | 2.04% | -0.64p | n/a | 0.0 | 0.00% | £79.45 | n/a | - | n/a |
Ikigai Ventures Limited Npv | 46.50p | 0.00% | -0.010p | n/a | 0.0 | 0.00% | £9.62 | n/a | - | n/a |
Invesco Markets Invesco FTSE 100 Ucits ETF | 8,696.00p | 10.86% | n/a | n/a | n/a | n/a | £10.71 | n/a | - | n/a |
Marwyn Acquisition Company II Limited (DI) | 0.000p | 0.00% | -27.78p | 0.0 | 0.0 | 0.00% | n/a | n/a | - | n/a |
Milton Capital | 0.75p | -28.57% | -0.100p | n/a | 0.0 | 0.00% | £0.75 | n/a | - | n/a |
NB Distressed Debt Investment Fund Limited Ext Shs | $0.57 | 7.55% | 9.86¢ | 5.8 | n/a | 0.00% | $25.21 | n/a | - | n/a |
Oryx International Growth Fund Ltd. | 1,300.00p | 11.11% | n/a | n/a | n/a | n/a | £182.00 | n/a | - | n/a |
Seed Capital Solutions | 0.88p | 0.00% | -0.23p | n/a | 0.0 | 0.00% | £1.62 | n/a | - | n/a |
Tirupati Graphite | 4.50p | -12.62% | -2.59p | n/a | 0.0 | 0.00% | £5.59 | n/a | - | n/a |
Trident Royalties | 36.10p | 3.14% | 0.82¢ | 55.2 | 0.0 | 0.00% | £105.80 | n/a | - | n/a |
You are here: research